ArticleFrontiers in aging neuroscience2025
Research trends and frontiers of astrocytes in cognitive impairment: a bibliometric analysis from 2015 to 2024.
Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Astrocytes, constituting the predominant glial cell population with in the central nervous system, have emerged as a focal point of investigation due to their multifaceted roles and therapeutic implications in cognitive disorders. Despite the growing body of research, there has yet to be a bibliometric analysis to determine research trends and hotspots in this field. Methods: We searched for publications related to cognitive impairment and astrocytes in the Web of Science Core Collection (WoSCC), PubMed, and Scopus databases from January 1, 2015, to December 31, 2024. Using VOSviewer, CiteSpace software, and bibliometrix based on the R programming language, we performed visualization and bibliometric analysis of WoSCC data, covering aspects such as countries, institutions, authors, journals, keywords, and references. Additionally, we conducted equivalent searches in the Scopus and PubMed databases using the same keyword combinations, time range, and screening criteria. By verifying the consistency of time series, thematic focus, and country rankings across databases, we ensured the stability and universality of the results. Results: Over the past decade, investigations into the role of astrocytes in cognitive disorders have demonstrated a consistent upward trajectory, with the United States and China emerging as leading contributors. The primary focus has been on Alzheimer's disease, Parkinson's disease, VD, and Traumatic brain injury. The hippocampus has been identified as a critical brain region in these studies. Neuroinflammation has persisted as a central research focus and continues to represent a key direction for future investigations. Synaptic dysfunction is a recent research hotspot. The integration of single-cell sequencing technology has facilitated more comprehensive mechanistic analyses in this field. Multi-database validation results indicate that publication trends, thematic priorities, geographical distribution, and journal distribution exhibit macro-level stability. Conclusion: This study employed bibliometric methods to map the development trends and research hotspots in studies related to astrocytes and cognitive impairments over the past decade, and emphasized the importance of translating current research into clinical applications. This will provide insights and references for future studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.